Ad hoc publication
Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons
Since early 2020, the COVID-19 pandemic has had a dramatic impact on the way we live, with European countries having to introduce unprecedented measures to protect public health. As with all areas of life, drug consumption, related harms and drug markets have been impacted, as have the services...
Ad hoc publication
EMCDDA trendspotter briefing: Impact of COVID-19 on drug use and drug services in Western Balkans
The Western Balkans (Albania, Bosnia and Herzegovina, Kosovo*, Montenegro, North Macedonia and Serbia) registered the main waves of COVID-19 infections later than most of the EU countries, but containment strategies were implemented at the same time and with equal force as in the rest of Europe....
Ad hoc publication
EMCDDA Trendspotter briefing: impact of COVID-19 on patterns of drug use and drug-related harms in Europe
Since the start of 2020, European countries have been experiencing an unprecedented public health threat with the emergence of the coronavirus disease (COVID-19). In order to investigate the effects and implications of this pandemic for people who use drugs in Europe, the EMCDDA instigated a mixed-...
Ad hoc publication
EMCDDA trendspotter briefing - Impact of COVID-19 on drug services and help-seeking in Europe
Since the start of 2020, European countries have been experiencing an unprecedented public health threat with the emergence of the coronavirus disease (COVID-19). In order to investigate the effects and implications of this outbreak for drug services in Europe, the European Monitoring Centre for...
Timeline: EMCDDA preparedness and response
Over the past quarter of a century, the EMCDDA has expanded its monitoring capability to keep pace with revolutionary changes in the extent and nature of the drugs problem and in the world in which we live. By complementing data routinely submitted by Member States with information from an...
Recent changes in Europe’s cocaine market: results from an EMCDDA trendspotter study
Using trendspotter methodology, this report explores signs of increasing availability and consumption of cocaine in Europe, in an effort to increase our understanding of recent changes in the cocaine market. The study investigates the consequences of these developments on acute health harms linked...
Trendspotter manual: a handbook for the rapid assessment of emerging drug-related trends
This publication is a user-friendly guide, taking the reader, step by step, through the trendspotter methodology developed by the EMCDDA to explore emerging drug trends, new patterns of use, developing drug markets and technologies. The trendspotter method involves the rapid collection and...
Exploring new and emerging drug trends and developments in CELAC countries: joint report from the EMCDDA and COPOLAD workshop on trendspotter methodology
This report details the results of a two-day workshop on the EMCDDA’s trendspotter methodology held in Lisbon in November 2017. The workshop involved representatives from national drug observatories based in countries from the Community of Latin American and Caribbean States (CELAC), along with...
New psychoactive substances in prison
This report looks at the use of new psychoactive substances (NPS) in prison settings. This is a rapidly developing phenomenon, but empirical data are currently scarce and patchy. There is growing evidence that NPS are responsible for a large share of drug-related problems in some European prisons...
Innovative methods for exploring new drug-related trends: the EMCDDA Trendspotter methodology (poster)
A Trendspotter study is a rapid information assessment that uses multiple social research methods to explore a topic of interest or concern. The approach was developed and has been used by the EMCDDA since 2011 as a tool to complement other routine drug monitoring methodologies.
High-risk drug use and new psychoactive substances – results from an EMCDDA trendspotter study
This report provides a first look at the emergence of more problematic forms of use of new psychoactive substances among a range of demographic groups, including opioid and amphetamine injectors, prisoners, the homeless and men who have sex with men. It explores, in particular, the use of synthetic...
Recent changes in Europe’s MDMA/ecstasy market – results from an EMCDDA trendspotter study
This report explores the recent resurgence in use of MDMA in Europe and increased availability of high-strength MDMA tablets, crystals and powders. It notes that the picture is not uniform across European countries, and while overall the region’s MDMA market is now in a period of consolidation,...
The internet and drug markets —summary of results from an EMCDDA Trendspotter study
The speed with which the Internet is transforming drug markets poses a major challenge to law enforcement, public health, research and monitoring agencies. This study aims to raise understanding of the current online supply of drugs and to map the range of Internet markets in existence.
EMCDDA Trendspotter study on fentanyl in Europe
The EMCDDA Trendspotter case study on Fentanyl in Europe was undertaken during September and October 2012. It culminated in an expert meeting in Lisbon on 9–10 October 2012. The aim of the study was to increase understanding of the availability and illicit use of fentanyl in Europe, with a specific...
Summary report from EMCDDA Trendspotter meeting 18–19 October 2011
The first EMCDDA Trendspotter meeting, on Recent shocks in the European heroin market: explanations and ramifications, took place in Lisbon on 18–19 October 2011. The purpose of the meeting was to increase understanding of the 2010/2011 heroin shortage reported by some European countries and to...